RxDoctor Payments Data

Tabitha Bane

Nurse Practitioner · Fort Wayne, INNPI 1417339896

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.4% of the total across 13 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by AbbVie at 31.3% of the total. 2025 is the largest year on record at $117, 4.9 times the $24 reported in 2021. That places this record below the midpoint for nurse practitioner clinicians in IN, where the typical reported total is $160.

$232in general payments, 2019–2025

Across 13 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$73
  • Novo Nordisk$26
  • Abbott$24
  • CSL Behring$20
  • Livanova USA, Inc.$18
  • Neurocrine Biosciences, Inc.$18
  • plus $53 from 4 others

What the payments were for

  • Food & beverage$21291%
  • Education$209%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$232 in reported general payments places this provider in the 50th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana →

Medicare billing

Part B allowed, 2024
$16,666
Medicare patients
109
Services billed
236

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen56$401
Levetiracetam19$197
Dexamethasone13$179
Cyclobenzaprine Hcl42$149
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$126
Diazepam12$15

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Fort Wayne

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →